Novo Nordisk Share Price Target 2025: Technical Outlook & Analyst Forecasts
Novo Nordisk (NYSE: NVO) is currently trading near $51, with analysts offering mixed forecasts for 2025. While some brokerages, including UBS and BofA, have trimmed their targets to $48–$53, broader consensus estimates suggest potential upside toward $90–$94. Technical charts show strong support around $36, with resistance at $60–$78, making these key levels to watch. Recent…